Ecosystem Barriers and Facilitators Linked to the Fear of Cancer Recurrence: An Umbrella Review.

Benjamin Caumeil, Nicolas Bazine, Axel Maugendre, Sarah Calvin
Author Information
  1. Benjamin Caumeil: Management Sport Cancer Laboratory (UR 20122035V), Faculty of Sport Sciences, Aix-Marseille University, 13008 Marseille, France. ORCID
  2. Nicolas Bazine: Laboratoire 2LPN, UR7489, Université de Lorraine, 54000 Nancy, France. ORCID
  3. Axel Maugendre: Management Sport Cancer Laboratory (UR 20122035V), Faculty of Sport Sciences, Aix-Marseille University, 13008 Marseille, France. ORCID
  4. Sarah Calvin: Management Sport Cancer Laboratory (UR 20122035V), Faculty of Sport Sciences, Aix-Marseille University, 13008 Marseille, France. ORCID

Abstract

The fear of cancer recurrence is an important topic in the healthcare field. In general, approximately 40% of survivors experience high levels of fear of recurrence. This study aims to fill this gap by synthesizing the findings of systematic reviews studies investigating ecosystems, correlates or predictors, and barriers and facilitators of fear of cancer recurrence among cancer survivors. An umbrella meta-synthesis was conducted using the following databases: MEDLINE, PsycINFO, PsycARTICLES, CINAHL, Business source premier, and SOCindex, ending in April 2024 with PRISMA methods. A total of 24 systematic reviews, representing 729 articles, were included in the study. In total, six ecosystems were identified, including family, work, friends, the healthcare system, caregivers, and religion. As part of this umbrella review, 55 specific ecosystemic factors were identified that may contribute to fear of cancer recurrence. Furthermore, the umbrella review identified 12 facilitators and 12 barriers related to fear of cancer recurrence. This umbrella meta-synthesis contributed significantly to our review's strength in synthesizing the main ecosystem and its influence on fears of cancer recurrence. Understanding the interdependence of ecosystems should enable future research on intervention effectiveness or the development of interventions that could reduce the fear of cancer recurrence.

Keywords

References

  1. Psychooncology. 2022 Jun;31(6):879-892 [PMID: 35388525]
  2. J Epidemiol Glob Health. 2019 Dec;9(4):217-222 [PMID: 31854162]
  3. J Clin Oncol. 2019 Nov 1;37(31):2899-2915 [PMID: 31532725]
  4. Front Psychol. 2022 Jul 13;13:947669 [PMID: 35910981]
  5. J Adv Nurs. 2023 Sep;79(9):3192-3213 [PMID: 36918983]
  6. JAMA. 1997 Jun 25;277(24):1940-4 [PMID: 9200634]
  7. Eur J Oncol Nurs. 2021 Feb;50:101882 [PMID: 33421929]
  8. Cancer Nurs. 2022 Jan-Feb 01;45(1):E10-E26 [PMID: 32657897]
  9. Psychooncology. 2021 Aug;30(8):1185-1195 [PMID: 33880822]
  10. J Cancer Surviv. 2014 Sep;8(3):485-96 [PMID: 24756313]
  11. Health Soc Care Community. 2019 Sep;27(5):1126-1134 [PMID: 31144395]
  12. BMJ Open. 2020 Oct 30;10(10):e040025 [PMID: 33127636]
  13. J Cancer Surviv. 2017 Feb;11(1):41-47 [PMID: 27412726]
  14. J Cancer Surviv. 2009 Jun;3(2):117-27 [PMID: 19322661]
  15. Front Psychiatry. 2022 Sep 23;13:973012 [PMID: 36213907]
  16. J Clin Nurs. 2008 Nov;17(21):2895-909 [PMID: 19012759]
  17. Psychooncology. 2023 Jan;32(1):3-5 [PMID: 36456764]
  18. Front Psychol. 2021 May 03;12:621850 [PMID: 34012412]
  19. J Adv Nurs. 2022 Oct;78(10):3069-3082 [PMID: 35696315]
  20. Asia Pac J Clin Oncol. 2019 Oct;15(5):e68-e78 [PMID: 31215167]
  21. Psychooncology. 2013 May;22(5):978-86 [PMID: 22674873]
  22. Int J Environ Res Public Health. 2023 Apr 12;20(8): [PMID: 37107768]
  23. Health Psychol. 2023 Mar;42(3):182-194 [PMID: 36862474]
  24. Psychooncology. 2019 Apr;28(4):675-686 [PMID: 30703261]
  25. Psychooncology. 2023 Sep;32(9):1348-1358 [PMID: 37571918]
  26. Bone Marrow Transplant. 2020 Jun;55(6):997-999 [PMID: 32123291]
  27. Support Care Cancer. 2019 Nov;27(11):4055-4067 [PMID: 31286237]
  28. Psychooncology. 2023 Aug;32(8):1173-1191 [PMID: 37303263]
  29. Psychooncology. 1997 Jun;6(2):95-105 [PMID: 9205967]
  30. Cancer Nurs. 2022 Sep-Oct 01;45(5):406-415 [PMID: 34560707]
  31. Psychooncology. 2023 Feb;32(2):266-274 [PMID: 36385563]
  32. J Cancer Surviv. 2022 Jun;16(3):590-603 [PMID: 33950477]
  33. Syst Rev. 2021 Mar 29;10(1):89 [PMID: 33781348]
  34. Psychooncology. 2013 Jan;22(1):1-11 [PMID: 22232030]
  35. Support Care Cancer. 2022 May;30(5):3665-3690 [PMID: 34982226]
  36. Thyroid. 2024 May;34(5):541-558 [PMID: 38368547]
  37. BMC Health Serv Res. 2014 Nov 21;14:579 [PMID: 25413154]
  38. Cancer Rep (Hoboken). 2019 Aug;2(4):e1172 [PMID: 32721129]
  39. Health Policy. 2019 Jul;123(7):611-620 [PMID: 31133444]
  40. Clin J Oncol Nurs. 2016 Dec 1;20(6):E155-E161 [PMID: 27857253]
  41. Nat Rev Cancer. 2012 Dec;12(12):835-48 [PMID: 23151603]
  42. J Am Diet Assoc. 2003 May;103(5):566-9 [PMID: 12728213]
  43. J Oncol Pract. 2019 Sep;15(9):e787-e797 [PMID: 31298966]
  44. Psychooncology. 2015 Jun;24(6):691-8 [PMID: 25060033]
  45. Psychol Health. 2022 Mar;37(3):350-374 [PMID: 33499649]
  46. Psychooncology. 2023 Aug;32(8):1240-1247 [PMID: 37231565]
  47. J Cancer Surviv. 2013 Sep;7(3):300-22 [PMID: 23475398]
  48. Int J Environ Res Public Health. 2021 Jan 17;18(2): [PMID: 33477253]
  49. Bone Marrow Transplant. 2021 Nov;56(11):2755-2762 [PMID: 34262141]
  50. Front Psychol. 2021 Apr 12;12:644932 [PMID: 33912113]
  51. BMJ Ment Health. 2023 Feb;26(1): [PMID: 36792173]
  52. Am J Public Health. 2003 Jan;93(1):31-7 [PMID: 12511380]
  53. Cancers (Basel). 2021 Sep 28;13(19): [PMID: 34638332]
  54. Am J Transl Res. 2022 Jul 15;14(7):4804-4811 [PMID: 35958474]
  55. J Cancer Surviv. 2016 Oct;10(5):814-31 [PMID: 26920873]
  56. Int J Environ Res Public Health. 2020 Jul 01;17(13): [PMID: 32630215]
  57. Ann Behav Med. 2024 Feb 10;58(3):147-155 [PMID: 38134347]
  58. Front Psychol. 2021 Jul 16;12:625654 [PMID: 34335354]
  59. Support Care Cancer. 2020 Sep;28(9):4173-4181 [PMID: 31900611]
  60. J Adv Nurs. 2009 Apr;65(4):724-36 [PMID: 19228235]
  61. Front Psychiatry. 2023 Mar 08;14:1136013 [PMID: 36970291]
  62. Depress Anxiety. 2011 Jul;28(7):551-9 [PMID: 21681863]
  63. Int J Environ Res Public Health. 2024 Apr 02;21(4): [PMID: 38673343]
  64. J Cancer Surviv. 2024 Mar 23;: [PMID: 38520600]
  65. Eur J Oncol Nurs. 2024 Jun;70:102570 [PMID: 38574419]
  66. Disabil Rehabil. 2017 Oct;39(21):2164-2172 [PMID: 27596990]
  67. Int J Environ Res Public Health. 2024 Mar 21;21(3): [PMID: 38541376]
  68. Acta Oncol. 2013 Aug;52(6):1102-9 [PMID: 23384721]
  69. Psychooncology. 2021 Apr;30(4):444-454 [PMID: 33314485]
  70. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-10 [PMID: 35561298]

MeSH Term

Humans
Fear
Ecosystem
Neoplasm Recurrence, Local
Cancer Survivors
Neoplasms

Word Cloud

Created with Highcharts 10.0.0cancerrecurrencefearumbrellaecosystemsbarriersfacilitatorsidentifiedreviewhealthcaresurvivorsstudysynthesizingsystematicreviewsmeta-synthesistotal12ecosystemimportanttopicfieldgeneralapproximately40%experiencehighlevelsaimsfillgapfindingsstudiesinvestigatingcorrelatespredictorsamongconductedusingfollowingdatabases:MEDLINEPsycINFOPsycARTICLESCINAHLBusinesssourcepremierSOCindexendingApril2024PRISMAmethods24representing729articlesincludedsixincludingfamilyworkfriendssystemcaregiversreligionpart55specificecosystemicfactorsmaycontributeFurthermorerelatedcontributedsignificantlyreview'sstrengthmaininfluencefearsUnderstandinginterdependenceenablefutureresearchinterventioneffectivenessdevelopmentinterventionsreduceEcosystemBarriersFacilitatorsLinkedFearCancerRecurrence:UmbrellaReviewoncology

Similar Articles

Cited By

No available data.